Literature DB >> 15585089

Construction of an infectious HIV type 1 molecular clone from an African patient with a subtype D/C Recombinant Virus.

Binshan Shi1, Sean M Philpott, Barbara Weiser, Carla Kuiken, Cheryl Brunner, Guowei Fang, Keith R Fowke, Francis A Plummer, Sarah Rowland-Jones, Job Bwayo, Aggrey O Anzala, Joshua Kimani, Rupert Kaul, Harold Burger.   

Abstract

The majority of HIV-1 infections worldwide occur in Africa, where subtype B viruses are rare and intersubtype recombinants are common. Pathogenesis and vaccine studies need to focus on viruses derived from African patients, and infectious HIV-1 molecular clones can be useful tools. To clone non-B subtypes and recombinant viruses from patients, we cultivated HIV-1 from the plasma of a Kenyan long-term survivor. Viral DNA was cloned into a plasmid, which was transfected into COS cells; progeny virus was propagated in PBMCs. Sequence analyses revealed that both the patient's plasma HIV-1 RNA and the cloned DNA genomes were recombinants between subtypes D and C; subtype C sequences comprised the nef and LTR regions. The cloned virus used the CCR5 coreceptor and did not form syncytia in vitro. This infectious HIV-1 subtype D/C recombinant molecular clone obtained from a Kenyan long-term survivor promises to be useful to study pathogenesis and vaccine design.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15585089     DOI: 10.1089/aid.2004.20.1015

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  2 in total

1.  Parental LTRs are important in a construct of a stable and efficient replication-competent infectious molecular clone of HIV-1 CRF08_BC.

Authors:  Qiwei Zhang; Xiaomin Zhang; Hao Wu; Donald Seto; Hao-Jie Zhang; Zhiwei Chen; Chengsong Wan; Bo-Jian Zheng
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

2.  HIV-1 sequences in the epidemic suggest an alternative pathway for the generation of the Long Terminal Repeats.

Authors:  Pierre Cappy; Alice Moisan; Fabienne De Oliveira; Jean-Christophe Plantier; Matteo Negroni
Journal:  Sci Rep       Date:  2017-10-20       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.